Clinical Trial Update: Validation of New Markers of Glomerular Filtration Rate: Dota Gadolinium and Calcium EDTA (MultiGFR) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports termination of Phase 1/2 studies validating new markers of glomerular filtration rate using Dota Gadolinium and Calcium EDTA …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Calcium EDTA (calcium disodium edetate)
• Dota Gadolinium

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Renal Insufficiency, Chronic, Kidney Diseases | Phase 1, Phase 2 | Status: TERMINATED